Paper31337191
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
Varbanova VP and 3 others. Turk J Haematol, 2019. Cited by 14 papers, by iCite.
Cite this record
ConductScience Library. Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Papers, record 31337191. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31337191
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, MHC Class I | Major topic |
| Killer Cells, Natural | Major topic |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Receptors, KIR | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Case-Control Studies | |
| Genetic Predisposition to Disease | |
| Genotype | |
| Healthy Volunteers | |
| Ligands |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26983546 | The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphoma. | J Hematol Oncol | 2016 | https://conductscience.org/library/papers/26983546 | PubMed |
| 2 | 9126959 | A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. | J Immunol | 1997 | https://conductscience.org/library/papers/9126959 | PubMed |
| 3 | 9768753 | Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. | Immunity | 1998 | https://conductscience.org/library/papers/9768753 | PubMed |
| 4 | 17476328 | Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study. | PLoS One | 2007 | https://conductscience.org/library/papers/17476328 | PubMed |
| 5 | 24078689 | Large spectrum of HLA-C recognition by killer Ig-like receptor (KIR)2DL2 and KIR2DL3 and restricted C1 SPECIFICITY of KIR2DS2: dominant impact of KIR2DL2/KIR2DS2 on KIR2D NK cell repertoire formation. | J Immunol | 2013 | https://conductscience.org/library/papers/24078689 | PubMed |
| 6 | 27446203 | The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined? | Front Genet | 2016 | https://conductscience.org/library/papers/27446203 | PubMed |
| 7 | 15070694 | Down-regulation of HLA-A and HLA-Bw6, but not HLA-Bw4, allospecificities in leukemic cells: an escape mechanism from CTL and NK attack? | Blood | 2004 | https://conductscience.org/library/papers/15070694 | PubMed |
| 8 | 19493232 | Killer immunoglobulin-like receptors (KIR2DL2 and/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia. | Tissue Antigens | 2009 | https://conductscience.org/library/papers/19493232 | PubMed |
| 9 | 12689936 | Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. | Blood | 2003 | https://conductscience.org/library/papers/12689936 | PubMed |
| 10 | 19450876 | Killer cell immunoglobulin-like receptor gene polymorphisms in patients with leukemia: possible association with susceptibility to the disease. | Leuk Res | 2010 | https://conductscience.org/library/papers/19450876 | PubMed |
| 11 | 7532677 | The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. | J Exp Med | 1995 | https://conductscience.org/library/papers/7532677 | PubMed |
| 12 | 24518758 | The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia. | Blood | 2014 | https://conductscience.org/library/papers/24518758 | PubMed |
| 13 | 26472014 | Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians. | Hum Immunol | 2016 | https://conductscience.org/library/papers/26472014 | PubMed |
| 14 | 25281696 | NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual disease. | Clin Cancer Res | 2014 | https://conductscience.org/library/papers/25281696 | PubMed |
| 15 | 7716543 | Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. | Science | 1995 | https://conductscience.org/library/papers/7716543 | PubMed |
| 16 | 17617576 | KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. | J Immunol | 2007 | https://conductscience.org/library/papers/17617576 | PubMed |
| 17 | 21726204 | KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease. | Tissue Antigens | 2011 | https://conductscience.org/library/papers/21726204 | PubMed |
| 18 | 15973456 | A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. | Leukemia | 2005 | https://conductscience.org/library/papers/15973456 | PubMed |
| 19 | 20124216 | Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. | Blood | 2010 | https://conductscience.org/library/papers/20124216 | PubMed |
| 20 | 10381530 | Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. | Blood | 1999 | https://conductscience.org/library/papers/10381530 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42453788 | Parental KIR/HLA-C Profiles and Reproductive Failure: A Phenotype-Stratified Retrospective Analysis of Couples With Fertility Disorders. | Obstet Gynecol Int | 2026 | https://conductscience.org/library/papers/42453788 | PubMed |
| 40244151 | The Role of Killer Ig-like Receptors in Diseases from A to Z. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40244151 | PubMed |
| 39828905 | Association of killer immunoglobulin-like receptor genotypes and haplotypes with acute lymphoblastic leukemia risk. | Innate Immun | 2025 | https://conductscience.org/library/papers/39828905 | PubMed |
| 37454198 | Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients. | Sci Rep | 2023 | https://conductscience.org/library/papers/37454198 | PubMed |
| 37228595 | NK cell defects: implication in acute myeloid leukemia. | Front Immunol | 2023 | https://conductscience.org/library/papers/37228595 | PubMed |
| 36699439 | Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort. | Indian J Hematol Blood Transfus | 2023 | https://conductscience.org/library/papers/36699439 | PubMed |
| 32311889 | [Effect of KIR/HLA receptor-ligand mode on prognosis of single unrelated cord blood transplantation in patients with hematological malignancies]. | Zhonghua Xue Ye Xue Za Zhi | 2020 | https://conductscience.org/library/papers/32311889 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31337191
GET https://conductscience.org/api/papers/v1/31337191/references?page=2